Sort
21,453 grants matching “tuberculosis”
Vaccines for Extensively Drug Resistant Tuberculosis
$1,045,159William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2013 · AI
Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection
$1,044,582Kevin Loring Winthrop · Oregon Health & Science University · U01 · FY2023 · DC
Mouse models for paucibacillary persistence
$1,044,526Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI
Xenobiotic-Metabolizing Enzymes
$1,044,513Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,043,256Barry Dickman · Philadelphia Departmentof Public Health · U52 · FY2007 · PS
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,043,172Thomas R Hawn · University Of Washington · R61 · FY2019 · AI
Seattle Tuberculosis Research Advancement Center
$1,043,145Chetan Seshadri · University Of Washington · P30 · FY2023 · AI
Host-bacterial interactions determining the spectrum of Mtb transmission
$1,041,944Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Core B - Developmental
$1,041,383Ira B Wilson · Miriam Hospital · P30 · FY2019 · AI
MYCOBACTERIUM TUBERCULOSIS PROTEOME-WIDE EPITOPE DISCOVERY AND HOST TRANSCRIPTOME-WIDE T CELL PHENOTYPING IN HIGH DISEASE BURDEN POPULATIONS
$1,040,738John Altin · Translational Genomics Research Inst · N01 · FY2025 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
$1,039,959Adithya Cattamanchi · University Of California-Irvine · R01 · FY2022 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,039,049Victorio J Vaz · Arizona State Department Of Hlth Srvcs · U52 · FY2006 · PS
Efficacy and cost of HAART DOT in methadone clinics
$1,038,565Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · DA
Tuberculosis Research Unit
$1,037,577W. Henry Boom · Case Western Reserve University · N01 · FY2013 · AI
Tuberculosis Research Unit
$1,037,577W. Henry Boom · Case Western Reserve University · N01 · FY2013 · AI
GHESKIO HIV Clinical Trial Unit
$1,037,231Jean William Pape · Gheskio Center · UM1 · FY2018 · AI
Seattle Tuberculosis Research Advancement Center
$1,037,189Chetan Seshadri · University Of Washington · P30 · FY2024 · AI
Seattle Tuberculosis Research Advancement Center
$1,037,189Chetan Seshadri · University Of Washington · P30 · FY2025 · AI
Modeling Core
$1,035,428Nitin S Baliga · Seattle Children'S Hospital · U19 · FY2021 · AI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function
$1,034,989Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2018 · AI
National Resource For Advanced NMR Technology
$1,034,604Timothy A Cross · Florida State University · P41 · FY2019 · GM
National Resource For Advanced NMR Technology
$1,034,604Timothy A Cross · Florida State University · P41 · FY2020 · GM
Tri-Institutional Tuberculosis Research Advancement Center (TRAC)
$1,034,397Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · P30 · FY2022 · AI
International Tuberculosis Clinical Research
$1,034,058Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of novel proteins synthesis inhibitors for MDR tuberculosis
$1,034,057Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2010 · AI